Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Acitretin in Moderate to Severe Psoriasis
NCT00936065Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2009
- Primary completion
- Apr 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Pfizer. Started Jul 2009; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00936065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936065.